Augmented Reality in Pharma Manufacturing: What a HoloLens Pilot Taught Us About Adoption

Augmented reality in pharma manufacturing promises hands-free access to live production data, but a headset only pays off when it does something the existing tools cannot. In this project, a pharmaceutical manufacturer used Microsoft HoloLens to show operators real-time Industrial IoT data. Operators stayed with the standard HMI because the headset gave them no clear advantage in everyday work. Adoption improved only after the company redefined the business problem together with operators and adapted the technology to real operational needs.

Below we walk through the case step by step and share four lessons for any smart factory initiative that starts with a pilot. The project is part of our wider digital manufacturing work. We believe manufacturing leaders should rely on reliable, real-time data to reach the real goals of Industry 4.0, because that data builds knowledge and awareness and shows which actions need improvement. By sharing completed projects and their pitfalls, we hope to help you avoid at least some of them on the way to digital transformation.

The challenge: becoming an innovation leader in pharmaceutical production

A pharmaceutical company wanted to strengthen its position as an innovator by actively testing modern technologies. The key challenge was to integrate these innovations into the production area skilfully and effectively, so that data could be collected and analysed in real time.

The business motivation was clear. The company wanted to show that it belongs to the leading group, the „close peloton”, of manufacturers digitalising production, and to raise its market competitiveness as a result. In pharmaceutical production, any change of this kind also has to fit validated processes and strict GMP quality requirements.

The approach: real-time IIoT data visualised on Microsoft HoloLens

With the support of TT PSC experts, the company implemented a solution that integrated data collection from the manufacturing process. This Industrial IoT layer made production data available to operators in real time.

The key element was data visualisation in augmented and virtual reality (AR/VR) on Microsoft HoloLens headsets. Operators could see IIoT data in real time, directly in their field of view, which was meant to improve the efficiency and precision of their work. The project had two further aims: to increase employee engagement and to build a strong market position as an innovator through the use of the newest tools.

Why augmented reality in pharma manufacturing lost to the standard HMI

The AR/VR application looked impressive on the headsets, but it did not deliver the expected results. In everyday operations it showed no sufficient advantage over the standard HMI (human-machine interface), the touch panel or screen mounted on the machine. Operators were reluctant to wear the headsets during their duties, so adoption of the technology stayed low.

This is a common pattern in industrial augmented reality. The HMI is already where operators work: it is fixed at the machine, always on and familiar. A headset has to earn its place by doing something the panel cannot. The comparison below shows where each interface typically fits.

In pharmaceutical plants, wearables also have to fit gowning, cleaning and validation procedures, which adds friction to every shift. That makes a clear, task-level benefit even more important.

The correction: redefining the business problem with operators

In response, the company reassessed its actual business needs and the outcomes it expected. The technology was then adapted to real operational requirements, so that the available tools could be used more effectively. Operators were consulted throughout this process to better understand their needs and expectations. The result was a more practical, user-friendly solution with better adoption and usability in everyday operations.

Questions to ask before choosing the operator interface

The case points to a simple check worth running before any AR, VR or HMI decision:

• Which task or decision should the data support, and how will you measure the improvement?
• Where is the operator when they need the information, and are their hands free?
• What does the current HMI or MES screen already do well?
• What will it take to roll the solution out to other lines and sites?

The result: a tool built around real user needs

Operators first rejected the AR/VR solution because it offered no substantial advantage over the existing HMI. After re-evaluating the approach and tailoring the technology to real user needs, the company developed a more effective tool. The experience showed how important it is to adapt technology to the specific requirements of end users, which ultimately led to better use of the available resources.

Four lessons for scaling augmented reality in pharma manufacturing

The project leads to four conclusions that apply to AR pilots and to smart factory initiatives in general.

1. Define business goals first: proof of value, not proof of concept

Clearly defined business goals are the key to evaluating results. A proof of concept shows that a technology works. A proof of value shows that it improves a business outcome agreed before the project started, which is the question management actually needs answered.

2. Set a precise technical scope

A well-defined technical scope is crucial for managing budgets and timelines while keeping a strong cost-to-value ratio. It also makes it easier to compare the new solution with the tools operators already use.

3. Do not let fascination with technology drive the project

Innovation and fascination with new technologies should not be the only motivations. When they are, it is easy to get stuck in the pilot phase, a trap often called pilot purgatory. The Industry 4.0 use cases with measurable results all start from a production problem, not from a device.

4. Design every pilot for scale

Even pilot projects should be designed with future scalability and broader implementation in mind. In practice, this means a data architecture that can serve more lines and sites, integration with systems such as MES, and a plan for the next phases, as described in our digital transformation in manufacturing roadmap.

Where augmented reality fits in digital manufacturing

Augmented reality in pharma manufacturing is an interface, not a strategy. Its value depends on the connected operations behind it: machine data collected through Industrial IoT and a Unified Namespace, production execution in a manufacturing execution system (MES), and wider manufacturing operations management (MOM) covering quality, maintenance and scheduling. With that foundation in place, the same data can drive production monitoring with OEE, predictive maintenance alerts and digital twin models, whether operators see them on an HMI, a tablet or a headset.

AR is most useful where work is hands-busy or knowledge-intensive, for example in assisted worker guidance and augmented remote assistance. AI for manufacturing then turns the collected data into recommendations, and the same connected data model can later support supply chain digitalisation. That is why our digital manufacturing approach starts with losses, not technology.

FAQ: augmented reality in pharma manufacturing

More examples from our digital manufacturing projects

• Root cause analysis in manufacturing: how machine learning traced unstable casting quality
• Systems integration and data modelling in semiconductor manufacturing
• Why data collection and storage decide the success of predictive maintenance
• Improving KPIs on semi-automated FMCG production lines
• Digitalising reporting processes in glass packaging manufacturing
• Data visualisation in components manufacturing for automation